---
title: "Sanyuan Biotechnology: Net profit of 24.914 million yuan in the first quarter of 2025, a year-on-year increase of 2.75%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237882607.md"
description: "Sanyuan Biotechnology announced that its revenue for the first quarter of 2025 was 150 million yuan, a year-on-year decrease of 21.73%; net profit was 24.914 million yuan, a year-on-year increase of 2.75%"
datetime: "2025-04-28T14:23:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237882607.md)
  - [en](https://longbridge.com/en/news/237882607.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237882607.md)
generator: "portal-rs"
---

# Sanyuan Biotechnology: Net profit of 24.914 million yuan in the first quarter of 2025, a year-on-year increase of 2.75%

Sanyuan Biotechnology announced that its revenue for the first quarter of 2025 was 150 million yuan, a year-on-year decrease of 21.73%; net profit was 24.914 million yuan, a year-on-year increase of 2.75%

### Related Stocks

- [301206.CN](https://longbridge.com/en/quote/301206.CN.md)

## Related News & Research

- [RCS - Vivo Energy Limited - Notice of Meeting – 2026 Interim Results](https://longbridge.com/en/news/297161642.md)
- [Frequentis wins ASTRID deal to modernize Belgium emergency control room communications](https://longbridge.com/en/news/297141567.md)
- [11:00 ETCizzle Bio Highlights CIZ1B Biomarker Blood Test for Lung Cancer at Next Generation Dx Summit](https://longbridge.com/en/news/297064751.md)
- [Bioretec hosts media event highlighting 500,000 Activa bioresorbable orthopedic implants sold worldwide](https://longbridge.com/en/news/297047388.md)
- [Embassy Bancorp, Inc. Announces Results of Operations as of and for the Three and Six Months Ended June 30, 2026 | EMYB Stock News](https://longbridge.com/en/news/296930370.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**